The main interest of my lab is to identify alternative splicing events that play a role in the development and/or maintenance of cancer, to study the cis and trans effectors involved, to understand what causes the loss of tight splicing control in cancer cells, and, ultimately, to develop means to control such events in a therapeutic perspective.